Conmy Dosage/Direction for Use

Benign Prostatic Hyperplasia: Initial dose: 1 mg at bedtime is the starting dose for all patients, and this dose should not be exceeded as an initial dose. Patients should be closely followed during initial administration in order to minimize the risk of severe hypotensive response.
Subsequent dose: the dose should be increased at intervals of 7 days stepwise fashion to 2 mg, 5 mg or 10 mg once daily to achieve the desired improvement of symptoms and/or flow rates. Doses of 10 mg once daily are generally required for the clinical response. Therefore, treatment with 10 mg for a minimum of 4-6 weeks may be required to assess whether a beneficial response has been achieved. Some patients may not achieve a clinical response despite appropriate titration. Although some additional patients responded to a 20 mg daily dose, there was an insufficient number of patients studied to draw definitive conclusions about this dose. There are insufficient date to support the use of higher doses for those patients who show inadequate or no response to 20 mg daily. If terazosin administration is discontinued for several days or longer therapy should be reinstituted using the initial regimen or as prescribed by physician.
Hypertension: Following oral administration its effects are seen within 15 minutes and may last for up to 24 hours permitting once daily dosage. To avoid the risk of collapse which may occur in some patients after the first dose the initial dose is the equivalent of 1 mg of terazosin at bedtime, increasing gradually at intervals of 7 days according to the patients response, to usual maximum of 20 mg of terazosin daily. The usual maintenance dose is 2 mg to 10 mg daily or as prescribed by a physician.